000 01731 a2200469 4500
005 20250514075146.0
264 0 _c20040121
008 200401s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood-2002-11-3612
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHolleman, Amy
245 0 0 _aResistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
_h[electronic resource]
260 _bBlood
_cDec 2003
300 _a4541-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAntineoplastic Agents
_xclassification
650 0 4 _aApoptosis
_xphysiology
650 0 4 _aAsparaginase
_xpharmacology
650 0 4 _aCaspase 3
650 0 4 _aCaspases
_xmetabolism
650 0 4 _aChild
650 0 4 _aDaunorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Multiple
_xphysiology
650 0 4 _aDrug Resistance, Neoplasm
_xphysiology
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMembrane Lipids
_xmetabolism
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aNeoplastic Stem Cells
_xdrug effects
650 0 4 _aPhosphatidylserines
_xmetabolism
650 0 4 _aPoly(ADP-ribose) Polymerases
_xmetabolism
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aPrednisolone
_xpharmacology
650 0 4 _aVincristine
_xpharmacology
700 1 _aden Boer, Monique L
700 1 _aKazemier, Karin M
700 1 _aJanka-Schaub, Gritta E
700 1 _aPieters, Rob
773 0 _tBlood
_gvol. 102
_gno. 13
_gp. 4541-6
856 4 0 _uhttps://doi.org/10.1182/blood-2002-11-3612
_zAvailable from publisher's website
999 _c12693010
_d12693010